# Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation

> **NCT03140631** · PHASE4 · COMPLETED · sponsor: **University of Michigan** · enrollment: 153 (actual)

## Conditions studied

- Atrial Fibrillation
- Catheter Ablation

## Interventions

- **DRUG:** Protamine Sulfate

## Key facts

- **NCT ID:** NCT03140631
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-23
- **Primary completion:** 2017-11-16
- **Final completion:** 2018-04-03
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03140631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03140631, "Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03140631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*